Clinical Trial Update: A Real-world Study of Tenecteplase Versus Alteplase for Thrombolysis in Patients Within 4.5 H of Onset of Ischemic Stroke

View source ↗

Summary

A real-world study is recruiting to compare tenecteplase and alteplase for thrombolysis in patients with acute ischemic stroke within 4.5 hours of onset.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Alteplase (alteplase)
• Tenecteplase (tenecteplase)

Snippet

Sponsor: Tianjin Huanhu Hospital | Conditions: Stroke Acute, Tenecteplase | Status: RECRUITING